Stem Cell Cryopreservation Global Market Report 2025
상품코드:1889588
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
줄기세포 동결보존 시장 규모는 최근 급속히 확대되고 있습니다. 2024년 34억 8,000만 달러로 평가되었고, 2025년에는 41억 7,000만 달러에 달할 것으로 추정되며, CAGR 19.9%로 성장이 전망되고 있습니다. 지금까지의 성장은 줄기세포 치료에 대한 인지도 향상, 재생 의료 보급 확대, 제대혈 뱅크 수요 증가, 의료 인프라 확충, 생명공학 분야 투자 확대 등이 요인으로 보입니다.
줄기세포 동결보존 시장 규모는 향후 수년간 급속한 성장이 예상됩니다. 2029년에는 85억 2,000만 달러에 달할 것으로 예측되며, CAGR 19.6%로 성장할 전망입니다. 예측 기간의 성장요인으로는 줄기세포 연구를 지원하는 정부 시책 확대, 만성질환의 유병률 상승, 재생 의료에 대한 자금 증가, 민간 줄기세포 뱅크 서비스의 성장, 줄기세포의 임상 용도 확대 등을 들 수 있습니다. 예측 기간 동안 예상되는 주요 동향으로는 동결보존 기술의 진보, 세포 보존 솔루션의 혁신, 자동 동결 시스템의 개발, 줄기세포 치료 연구의 진전, 맞춤형 의료 용도의 진보 등을 들 수 있습니다.
변성 질환 증가 추세는 줄기세포 동결보존 시장의 성장을 가속할 것으로 예측됩니다. 조직과 장기의 진행성 열화를 수반하는 변성 질환은 세계의 노화에 따라 증가하는 경향이 있습니다. 줄기세포 동결보존 기술을 통해 생존 가능한 줄기세포를 장기 보존할 수 있어 손상된 조직의 수리 및 교체를 목적으로 한 재생 의료의 즉응원을 제공합니다. 예를 들어, 알츠하이머병 협회에 따르면, 2023년 시점에서 65세 이상의 미국인 약 670만 명이 알츠하이머형 치매를 앓고 있으며, 2060년까지 1,380만 명에 달할 것으로 예측되고 있습니다. 이러한 변성 질환 증가는 줄기세포 동결보존 기술에 의해 지원되는 재생 의료에 대한 강한 수요를 창출하고 있습니다.
시장의 각 회사는 세포 생존율을 높이고 확장 가능한 치료법 개발을 지원하는 혁신적인 동결 솔루션에 주력하고 있습니다. 첨단 동결보존 배지는 동결 및 해동 시 줄기세포를 보호하고 자동화에 적합한 동결 시스템은 재현성 있는 대규모 처리를 가능하게 합니다. 2024년 4월 미국 바이오테크놀러지 기업 Pluristyx사는 다능성 및 감수성이 높은 줄기세포용으로 설계된 합성 및 동물 유래 성분 프리의 동결보존 배지 'PluriFreeze'를 발표했습니다. 본 솔루션은 해동 후 생존율과 기능적 무결성을 향상시키고, 자동화 워크플로우와의 통합을 실현하며, 임상 및 연구 분야에서의 확장 가능한 용도를 지원합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향 및 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석 및 전략 분석 프레임워크
세계의 줄기세포 동결보존 시장 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인 및 억제요인)
최종 이용 산업의 분석
세계의 줄기세포 동결보존 시장 : 성장률 분석
세계의 줄기세포 동결보존 시장 실적 : 규모 및 성장(2019-2024년)
세계의 줄기세포 동결보존 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
세계의 줄기세포 동결보존 시장 : 총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 줄기세포 동결보존 시장 : 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
배아 줄기세포
성체 줄기세포
유도 다능성 줄기세포
세계의 줄기세포 동결보존 시장 : 용도별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
세포 동결 배지
기기 및 소모품
세계의 줄기세포 동결보존 시장 : 최종 사용자별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
바이오의약품기업
연구기관
혈액은행
체외수정(IVF)(IVF) 클리닉
세계의 줄기세포 동결보존 시장 : 배성 줄기세포 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
인간 배아 줄기세포
마우스 배아 줄기세포
영장류 배아 줄기세포
기타 배아 줄기세포
세계의 줄기세포 동결보존 시장 : 성체 줄기세포 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
조혈 줄기세포
중간엽 줄기세포
신경 줄기세포
상피 줄기세포
세계의 줄기세포 동결보존 시장 : 유도 다능성 줄기세포 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
섬유아세포 유래 iPS 세포
혈액세포 유래 iPSC
상피세포 유래 iPSC
제7장 지역별 및 국가별 분석
세계의 줄기세포 동결보존 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
세계의 줄기세포 동결보존 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도 및 기업 프로파일
줄기세포 동결보존 시장 : 경쟁 구도
줄기세포 동결보존 시장 : 기업 프로파일
Thermo Fisher Scientific Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Danaher Corporation : 개요, 제품 및 서비스, 전략 및 재무 분석
Corning Incorporated : 개요, 제품 및 서비스, 전략 및 재무 분석
Lonza Group Ltd. : 개요, 제품 및 서비스, 전략 및 재무 분석
Sartorius AG : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Eppendorf SE
Vitalant Inc.
BioLife Solutions Inc.
Cryoviva Biotech Private Limited.
HiMedia Laboratories Private Limited
Cryo-Cell International Inc.
Celularity Inc.
PromoCell GmbH
Creative Biolabs Inc.
StemCyte Inc.
Reprocell Inc.
OriGen Biomedical Inc.
American CryoStem Corporation
Ossium Health Inc.
Pluristyx Inc.
제32장 세계 시장 경쟁 벤치마킹 및 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문 및 전략
줄기세포 동결보존 시장(2009년) : 새로운 기회를 제공하는 국가
줄기세포 동결보존 시장(2009년) : 새로운 기회를 제공하는 부문
줄기세포 동결보존 시장(2009년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
AJY
영문 목차
영문목차
Stem cell cryopreservation refers to the process of storing stem cells at ultra-low temperatures to preserve their viability and biological functions for long-term use. This method enables stem cells to be safely maintained for future therapeutic applications, research purposes, or transplantation.
The main types of stem cell cryopreservation include embryonic stem cells, adult stem cells, and induced pluripotent stem cells. Embryonic stem cells are pluripotent cells derived from the inner cell mass of a blastocyst, with the ability to differentiate into any cell type in the body. They are used across various applications, including cell freezing media, equipment, and consumables, and serve a range of end users such as biopharmaceutical companies, research institutes, blood banks, and in vitro fertilization (IVF) clinics.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.
The stem cell cryopreservation market research report is one of a series of new reports from The Business Research Company that provides stem cell cryopreservation market statistics, including stem cell cryopreservation industry global market size, regional shares, competitors with a stem cell cryopreservation market share, detailed stem cell cryopreservation market segments, market trends and opportunities, and any further data you may need to thrive in the stem cell cryopreservation industry. This stem cell cryopreservation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The stem cell cryopreservation market size has grown rapidly in recent years. It will grow from $3.48 billion in 2024 to $4.17 billion in 2025 at a compound annual growth rate (CAGR) of 19.9%. Growth during the historic period can be attributed to increasing awareness of stem cell therapies, greater adoption of regenerative medicine, rising demand for cord blood banking, expansion of healthcare infrastructure, and growing investments in biotechnology.
The stem cell cryopreservation market size is expected to see rapid growth in the next few years. It will grow to $8.52 billion in 2029 at a compound annual growth rate (CAGR) of 19.6%. Growth in the forecast period can be attributed to expanding government initiatives supporting stem cell research, the rising prevalence of chronic diseases, increasing funding for regenerative medicine, growth in private stem cell banking services, and the expanding clinical applications of stem cells. Major trends expected in the forecast period include technological advancements in cryopreservation, innovations in cell storage solutions, developments in automated freezing systems, progress in stem cell therapy research, and advancements in personalized medicine applications.
The rising prevalence of degenerative diseases is expected to drive the growth of the stem cell cryopreservation market. Degenerative diseases, which involve progressive deterioration of tissues or organs, are increasingly common due to the aging global population. Stem cell cryopreservation allows for the long-term storage of viable stem cells, providing a ready source for regenerative therapies aimed at repairing or replacing damaged tissues. For example, according to the Alzheimer's Association, approximately 6.7 million Americans aged 65 and older were living with Alzheimer's dementia in 2023, with projections reaching 13.8 million by 2060. This rising burden of degenerative diseases is creating strong demand for regenerative therapies supported by stem cell cryopreservation.
Companies in the market are focusing on innovative freezing solutions to enhance cell viability and support scalable therapy development. Advanced cryopreservation media protect stem cells during freezing and thawing, while automation-friendly freezing systems enable reproducible, large-scale processing. In April 2024, Pluristyx, Inc., a US-based biotechnology company, launched PluriFreeze, a synthetic, animal-origin-free cryopreservation medium designed for pluripotent and sensitive stem cells. The solution improves post-thaw viability and functional integrity, integrates with automated workflows, and supports scalable clinical and research applications.
In April 2025, BioLife Solutions Inc., a US healthcare technology company, acquired a 90% stake in PanTHERA CryoSolutions Inc. for $21.53 million. This acquisition enhances BioLife's technological capabilities in stem cell cryopreservation and expands its presence in advanced biobanking solutions, reinforcing the market's capacity to support regenerative therapies for degenerative diseases.
Major companies operating in the stem cell cryopreservation market are Thermo Fisher Scientific Inc., Danaher Corporation, Corning Incorporated, Lonza Group Ltd., Sartorius AG, Eppendorf SE, Vitalant Inc., BioLife Solutions Inc., Cryoviva Biotech Private Limited., HiMedia Laboratories Private Limited, Cryo-Cell International Inc., Celularity Inc., PromoCell GmbH, Creative Biolabs Inc., StemCyte Inc., Reprocell Inc., OriGen Biomedical Inc., American CryoStem Corporation, Ossium Health Inc., Pluristyx Inc.
North America was the largest region in the stem cell cryopreservation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in stem cell cryopreservation report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the stem cell cryopreservation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The stem cell cryopreservation market consists of revenues earned by entities by providing services such as collection and processing of stem cells, long-term storage and preservation, quality testing and viability assessment, regulatory compliance and documentation services, and insurance and risk management services. The market value includes the value of related goods sold by the service provider or included within the service offering. The stem cell cryopreservation market also includes sales of ultra-low-temperature storage equipment, rewarming devices, storage and retrieval systems, and ancillary support products. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Stem Cell Cryopreservation Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on stem cell cryopreservation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for stem cell cryopreservation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The stem cell cryopreservation market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
3. Stem Cell Cryopreservation Market Trends And Strategies
4. Stem Cell Cryopreservation Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Stem Cell Cryopreservation Growth Analysis And Strategic Analysis Framework
5.1. Global Stem Cell Cryopreservation PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Stem Cell Cryopreservation Market Growth Rate Analysis
5.4. Global Stem Cell Cryopreservation Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Stem Cell Cryopreservation Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Stem Cell Cryopreservation Total Addressable Market (TAM)
6. Stem Cell Cryopreservation Market Segmentation
6.1. Global Stem Cell Cryopreservation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Embryonic Stem Cell
Adult Stem Cell
Induced Pluripotent Stem Cell
6.2. Global Stem Cell Cryopreservation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cell Freezing Media
Equipment And Consumables
6.3. Global Stem Cell Cryopreservation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Biopharmaceutical Companies
Research Institutes
Blood Banks
In Vitro Fertilization (IVF) Clinics
6.4. Global Stem Cell Cryopreservation Market, Sub-Segmentation Of Embryonic Stem Cell, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Human Embryonic Stem Cell
Mouse Embryonic Stem Cell
Primate Embryonic Stem Cell
Other Embryonic Stem Cells
6.5. Global Stem Cell Cryopreservation Market, Sub-Segmentation Of Adult Stem Cell, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hematopoietic Stem Cell
Mesenchymal Stem Cell
Neural Stem Cell
Epithelial Stem Cell
6.6. Global Stem Cell Cryopreservation Market, Sub-Segmentation Of Induced Pluripotent Stem Cell, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Fibroblast-Derived iPSC
Blood Cell-Derived iPSC
Epithelial Cell-Derived iPSC
7. Stem Cell Cryopreservation Market Regional And Country Analysis
7.1. Global Stem Cell Cryopreservation Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Stem Cell Cryopreservation Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
